Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements.
Smith-Byrne K, Cerani A, Guida F, Zhou S, Agudo A, Aleksandrova K, Barricarte A, Barranco MR, Bochers CH, Gram IT, Han J, Amos CI, Hung RJ, Grankvist K, Nøst TH, Imaz L, Chirlaque-López MD, Johansson M, Kaaks R, Kühn T, Martin RM, McKay JD, Pala V, Robbins HA, Sandanger TM, Schibli D, Schulze MB, Travis RC, Vineis P, Weiderpass E, Brennan P, Johansson M, Richards JB.
Smith-Byrne K, et al. Among authors: robbins ha.
Cancer Epidemiol Biomarkers Prev. 2022 Oct 4;31(10):1966-1974. doi: 10.1158/1055-9965.EPI-21-1033.
Cancer Epidemiol Biomarkers Prev. 2022.
PMID: 35839461
Free PMC article.